MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer
Journal Article

Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer

2025
Request Book From Autostore and Choose the Collection Method
Overview
Background Colorectal cancer (CRC) is the third most deadly cancer in the world, accounting for approximately 10% of all cancer diagnoses and cancer-related deaths worldwide each year. In addition to recognized risk factors such as obesity, physical inactivity, and smoking, genetic predispositions significantly contribute to the risk of CRC. Methods Whole -exome sequencing (WES) was performed on a proband from a Chinese family diagnosed with CRC to identify potential variants. A germline pathogenic variant of the MSH6 gene was confirmed by Sanger sequencing. Immunohistochemistry (IHC) was used to verify the protein expression of MSH6 in the tumor sections. Prior to chemotherapy, the proband’s semen was cryopreserved in the Department of Reproductive Medicine. Preimplantation genetic testing for monogenic diseases (PGT-M) was subsequently employed to prevent vertical transmission of the pathogenic variant to the next generation. Results We confirmed a novel germline pathogenic variant of the MSH6 gene, c.3438 + 245_4082delinsTGAGACTACATTG, through WES and Sanger sequencing and verified MSH6 protein expression in tumor sections via IHC analysis. Finally, a healthy pregnancy was achieved via PGT-M technology. Conclusions Our study revealed a novel MSH6 germline pathogenic variant in CRC and expanded the spectrum of MSH6 variants involved in tumorigenesis. This study provides new insights into CRC caused by MSH6 germline pathogenic variants and demonstrates the potential application of PGT-M technology as an assisted reproductive method to prevent the vertical transmission of hereditary tumors.